Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
about
Gendermetrics of cancer research: results from a global analysis on lung cancer.Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis.Association Between the Asp312Asn, Lys751Gln, and Arg156Arg Polymorphisms in XPD and the Risk of Prostate Cancer.Gendermetrics of cancer research: results from a global analysis on prostate cancer.
P2860
Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
@en
Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
@nl
type
label
Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
@en
Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
@nl
prefLabel
Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
@en
Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
@nl
P2093
P2860
P31
P921
P356
P1433
P1476
Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
@en
P2093
Birong Huang
Feifan Xiao
Hongtao Li
Jiatong Li
P2860
P304
48488-48506
P356
10.18632/ONCOTARGET.17290
P407
P577
2017-04-20T00:00:00Z
2017-07-18T00:00:00Z